
### [MONDO:0015906](http://purl.obolibrary.org/obo/MONDO_0015906)
**Label:** rare disorder with hypergonadotropic hypogonadism

**Subclasses:** [MONDO:0016346](http://purl.obolibrary.org/obo/MONDO_0016346) (hydrocephalus-obesity-hypogonadism syndrome), [MONDO:0018544](http://purl.obolibrary.org/obo/MONDO_0018544) (X-linked adrenoleukodystrophy), [MONDO:0016385](http://purl.obolibrary.org/obo/MONDO_0016385) (hypogonadism-mitral valve prolapse-intellectual disability syndrome), [MONDO:0014143](http://purl.obolibrary.org/obo/MONDO_0014143) (Noonan syndrome 8), [MONDO:0008104](http://purl.obolibrary.org/obo/MONDO_0008104) (Noonan syndrome 1), [MONDO:0009417](http://purl.obolibrary.org/obo/MONDO_0009417) (hypergonadotropic hypogonadism-cataract syndrome), [MONDO:0009419](http://purl.obolibrary.org/obo/MONDO_0009419) (Woodhouse-Sakati syndrome), [MONDO:0010247](http://purl.obolibrary.org/obo/MONDO_0010247) (X-linked cerebral adrenoleukodystrophy), [MONDO:0011531](http://purl.obolibrary.org/obo/MONDO_0011531) (Noonan syndrome 2), [MONDO:0010448](http://purl.obolibrary.org/obo/MONDO_0010448) (Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome), [MONDO:0013379](http://purl.obolibrary.org/obo/MONDO_0013379) (Noonan syndrome 7), [MONDO:0015339](http://purl.obolibrary.org/obo/MONDO_0015339) (Adrenomyeloneuropathy), [MONDO:0012547](http://purl.obolibrary.org/obo/MONDO_0012547) (Noonan syndrome 4), [MONDO:0012690](http://purl.obolibrary.org/obo/MONDO_0012690) (Noonan syndrome 5), [MONDO:0012371](http://purl.obolibrary.org/obo/MONDO_0012371) (Noonan syndrome 3), [MONDO:0015600](http://purl.obolibrary.org/obo/MONDO_0015600) (X-linked intellectual disability, Cilliers type), [MONDO:0018997](http://purl.obolibrary.org/obo/MONDO_0018997) (Noonan syndrome), [MONDO:0011266](http://purl.obolibrary.org/obo/MONDO_0011266) (myotonic dystrophy type 2), [MONDO:0014691](http://purl.obolibrary.org/obo/MONDO_0014691) (Noonan syndrome 9), [MONDO:0013186](http://purl.obolibrary.org/obo/MONDO_0013186) (Noonan syndrome 6), [MONDO:0014693](http://purl.obolibrary.org/obo/MONDO_0014693) (Noonan syndrome 10), [MONDO:0008056](http://purl.obolibrary.org/obo/MONDO_0008056) (myotonic dystrophy type 1), [MONDO:0009420](http://purl.obolibrary.org/obo/MONDO_0009420) (primary hypergonadotropic hypogonadism-partial alopecia syndrome), [MONDO:0010617](http://purl.obolibrary.org/obo/MONDO_0010617) (male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome), [MONDO:0008915](http://purl.obolibrary.org/obo/MONDO_0008915) (dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome), [MONDO:0016818](http://purl.obolibrary.org/obo/MONDO_0016818) (Mikati-Najjar-Sahli syndrome), [MONDO:0010575](http://purl.obolibrary.org/obo/MONDO_0010575) (deafness-hypogonadism syndrome), [MONDO:0015601](http://purl.obolibrary.org/obo/MONDO_0015601) (X-linked intellectual disability, van Esch type), 

**Corr. equiv. classes:** [OMIM:300100](http://purl.obolibrary.org/obo/OMIM_300100), [OMIM:241080](http://purl.obolibrary.org/obo/OMIM_241080), [OMIM:240950](http://purl.obolibrary.org/obo/OMIM_240950), [Orphanet:2183](http://www.orpha.net/ORDO/Orphanet_2183), [OMIM:602668](http://purl.obolibrary.org/obo/OMIM_602668), [OMIM:300845](http://purl.obolibrary.org/obo/OMIM_300845), [Orphanet:163971](http://www.orpha.net/ORDO/Orphanet_163971), [Orphanet:163976](http://www.orpha.net/ORDO/Orphanet_163976), [OMIM:613224](http://purl.obolibrary.org/obo/OMIM_613224), [OMIM:616559](http://purl.obolibrary.org/obo/OMIM_616559), [OMIM:160900](http://purl.obolibrary.org/obo/OMIM_160900), [OMIM:605275](http://purl.obolibrary.org/obo/OMIM_605275), [OMIM:610733](http://purl.obolibrary.org/obo/OMIM_610733), [Orphanet:2229](http://www.orpha.net/ORDO/Orphanet_2229), [OMIM:613706](http://purl.obolibrary.org/obo/OMIM_613706), [OMIM:163950](http://purl.obolibrary.org/obo/OMIM_163950), [OMIM:307500](http://purl.obolibrary.org/obo/OMIM_307500), [OMIM:609942](http://purl.obolibrary.org/obo/OMIM_609942), [Orphanet:43](http://www.orpha.net/ORDO/Orphanet_43), [Orphanet:273](http://www.orpha.net/ORDO/Orphanet_273), [OMIM:241090](http://purl.obolibrary.org/obo/OMIM_241090), [Orphanet:139396](http://www.orpha.net/ORDO/Orphanet_139396), [Orphanet:2234](http://www.orpha.net/ORDO/Orphanet_2234), [Orphanet:2410](http://www.orpha.net/ORDO/Orphanet_2410), [Orphanet:2558](http://www.orpha.net/ORDO/Orphanet_2558), [Orphanet:139399](http://www.orpha.net/ORDO/Orphanet_139399), [OMIM:616564](http://purl.obolibrary.org/obo/OMIM_616564), [OMIM:615355](http://purl.obolibrary.org/obo/OMIM_615355), [Orphanet:2233](http://www.orpha.net/ORDO/Orphanet_2233), [OMIM:611553](http://purl.obolibrary.org/obo/OMIM_611553), [Orphanet:2232](http://www.orpha.net/ORDO/Orphanet_2232), [Orphanet:606](http://www.orpha.net/ORDO/Orphanet_606), [Orphanet:90646](http://www.orpha.net/ORDO/Orphanet_90646), [OMIM:212112](http://purl.obolibrary.org/obo/OMIM_212112), [OMIM:304350](http://purl.obolibrary.org/obo/OMIM_304350), [Orphanet:648](http://www.orpha.net/ORDO/Orphanet_648), [Orphanet:3464](http://www.orpha.net/ORDO/Orphanet_3464), [Orphanet:280679](http://www.orpha.net/ORDO/Orphanet_280679), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 42.27%
- Thing 42.25%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 42.25%
- [HP:0000815](http://purl.obolibrary.org/obo/HP_0000815) (Hypergonadotropic hypogonadism) and (not ([HP:0000079](http://purl.obolibrary.org/obo/HP_0000079) (Abnormality of the urinary system))) 41.03%
- [HP:0000815](http://purl.obolibrary.org/obo/HP_0000815) (Hypergonadotropic hypogonadism) and (not ([HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues))) 40.37%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 37.70%
- [HP:0000815](http://purl.obolibrary.org/obo/HP_0000815) (Hypergonadotropic hypogonadism) 37.61%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 34.92%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0000815](http://purl.obolibrary.org/obo/HP_0000815) (Hypergonadotropic hypogonadism) 34.48%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 34.00%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 32.45%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 32.36%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 31.33%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 29.15%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 28.74%


